Comparison of bupivacaine, ropivacaine and levobupivacaine with sufentanil for patient-controlled epidural analgesia during labor: a randomized clinical trial
- PMID: 20137366
Comparison of bupivacaine, ropivacaine and levobupivacaine with sufentanil for patient-controlled epidural analgesia during labor: a randomized clinical trial
Abstract
Background: Ropivacaine and levobupivacaine have been introduced into obstetric analgesic practice with the proposed advantages of causing less motor block and toxicity compared with bupivacaine. However, it is still controversial whether both anesthetics are associated with any clinical benefit relative to bupivacaine for labor analgesia. This study aimed to compare the analgesic efficacy, motor block and side effects of bupivacaine, ropivacaine and levobupivacaine at lower concentrations for patient-controlled epidural labor analgesia.
Methods: Four hundred and fifty nulliparous parturients were enrolled in this randomized clinical trial. A concentration of 0.05%, 0.075%, 0.1%, 0.125% or 0.15% of either bupivacaine (Group B), ropivacaine (Group R) or levobupivacaine (Group L) with sufentanil 0.5 microg/ml was epidurally administered by patient-controlled analgesia mode. Effective analgesia was defined as a visual analogue scale score was <or=30 mm. The relative median potency for each local anesthetic was calculated using a probit regression model. Parturients demographics, sensory and motor blockade, obstetric data, maternal side effects, hourly volumes of local anesthetic used, and others were also noted.
Results: There were no significant differences among groups in the numbers of effective analgesia, pain scores, hourly local anesthetic amount used, sensory and motor blockade, labor duration and mode of delivery, side effects and maternal satisfaction (P>0.05). The relative median potency was bupivacaine/ropivacaine: 0.828 (0.602-1.091), bupivacaine/levobupivacaine: 0.845 (0.617-1.12), ropivacaine/levobupivacaine: 1.021 (0.774-1.354), respectively. However, a significantly less number of effective analgesia and higher hourly local anesthetic use were observed in the concentration of 0.05% than those of >or=0.1% within each group (P<0.05).
Conclusions: Using patient-controlled epidural analgesia, lower concentrations of bupivacaine, ropivacaine and levobupivacaine with sufentanil produce similar analgesia and motor block and safety for labor analgesia. The analgesic efficacy mainly depends on the concentration rather than the type of anesthetics.
Similar articles
-
A randomized comparison of levobupivacaine, bupivacaine and ropivacaine with fentanyl, for labor analgesia.Int J Obstet Anesth. 2008 Apr;17(2):106-11. doi: 10.1016/j.ijoa.2007.10.003. Epub 2008 Mar 4. Int J Obstet Anesth. 2008. PMID: 18295469 Clinical Trial.
-
Minimum local analgesic concentrations of ropivacaine and levobupivacaine with sufentanil for epidural analgesia in labour.Int J Obstet Anesth. 2009 Jul;18(3):226-30. doi: 10.1016/j.ijoa.2009.02.002. Epub 2009 May 22. Int J Obstet Anesth. 2009. PMID: 19464878 Clinical Trial.
-
Efficacy of ropivacaine, bupivacaine, and levobupivacaine for labor epidural analgesia.J Clin Anesth. 2007 May;19(3):214-7. doi: 10.1016/j.jclinane.2006.11.003. J Clin Anesth. 2007. PMID: 17531731 Clinical Trial.
-
Focused review: ropivacaine versus bupivacaine for epidural labor analgesia.Anesth Analg. 2010 Aug;111(2):482-7. doi: 10.1213/ANE.0b013e3181e3a08e. Epub 2010 Jun 7. Anesth Analg. 2010. PMID: 20529986 Review.
-
Efficacy and safety of local anesthetics bupivacaine, ropivacaine and levobupivacaine in combination with sufentanil in epidural anesthesia for labor and delivery: a meta-analysis.Curr Med Res Opin. 2014 Nov;30(11):2279-89. doi: 10.1185/03007995.2014.946127. Epub 2014 Aug 5. Curr Med Res Opin. 2014. PMID: 25050590
Cited by
-
Pain management during labor: use of intermittent drug delivery devices for improvement of obstetric and neonatal outcome and reduction of healthcare burden: A large non-inferiority randomized clinical trial.J Anesth Analg Crit Care. 2021 Sep 1;1(1):2. doi: 10.1186/s44158-021-00003-w. J Anesth Analg Crit Care. 2021. PMID: 37386624 Free PMC article.
-
Effects of Ropivacaine in Patient-Controlled Epidural Analgesia on Uterine Electromyographic Activities during Labor.Biomed Res Int. 2018 Nov 7;2018:7162865. doi: 10.1155/2018/7162865. eCollection 2018. Biomed Res Int. 2018. PMID: 30533438 Free PMC article.
-
A prospective randomized double-blind study comparing the dose-response curves of epidural ropivacaine for labor analgesia initiation between parturients with and without obesity.Front Pharmacol. 2024 Feb 16;15:1348700. doi: 10.3389/fphar.2024.1348700. eCollection 2024. Front Pharmacol. 2024. PMID: 38434699 Free PMC article.
-
Patient-controlled epidural analgesia after Caesarean section: levobupivacaine 0.15% versus ropivacaine 0.15% alone or combined with fentanyl 2 µg/ml: a comparative study.Arch Med Sci. 2011 Aug;7(4):685-93. doi: 10.5114/aoms.2011.24140. Epub 2011 Sep 2. Arch Med Sci. 2011. PMID: 22291806 Free PMC article.
-
A Randomized Double Blinded Comparison of Epidural Infusion of Bupivacaine, Ropivacaine, Bupivacaine-Fentanyl, Ropivacaine-Fentanyl for Postoperative Pain Relief in Lower Limb Surgeries.J Clin Diagn Res. 2015 Sep;9(9):UC19-23. doi: 10.7860/JCDR/2015/15157.6459. Epub 2015 Sep 1. J Clin Diagn Res. 2015. PMID: 26500984 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources